Investors

Media Coverage

Caesars Report (August 19, 2020)

Elysee private equity investment BioAegis Therapeutics in the news on CNBC (May 11, 2020)

Caesar’s Report (Feb 1, 2019): Elysee reports C$0.06 EPS, Pays C$0.02 final dividend

Caesars Report (October 11, 2016): Interview with Guido Cloetens, Chairman of Elysee Development Corp.

Caesars Report (May 31, 2016): Elysee Development – An actively managed investment company


© 2020 Elysee Development Corp.
All rights reserved.